Parkman Healthcare Partners LLC Arcellx, Inc. Transaction History
Parkman Healthcare Partners LLC
- $687 Million
- Q4 2024
A detailed history of Parkman Healthcare Partners LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 44,492 shares of ACLX stock, worth $3.05 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
44,492
Previous 66,492
33.09%
Holding current value
$3.05 Million
Previous $5.55 Million
38.98%
% of portfolio
0.49%
Previous 0.78%
Shares
11 transactions
Others Institutions Holding ACLX
# of Institutions
223Shares Held
45MCall Options Held
434KPut Options Held
433K-
Paradigm Biocapital Advisors LP New York, NY4.37MShares$299 Million12.7% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$257 Million20.37% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$241 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.48MShares$238 Million8.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$228 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...